Compare NNNN & OBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NNNN | OBK |
|---|---|---|
| Founded | 2021 | 1912 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | N/A | 2018 |
| Metric | NNNN | OBK |
|---|---|---|
| Price | $26.00 | $41.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $44.29 |
| AVG Volume (30 Days) | 66.2K | ★ 217.8K |
| Earning Date | 01-01-0001 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.39% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.40 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $25.48 |
| Revenue Next Year | N/A | $5.79 |
| P/E Ratio | $446.57 | ★ $18.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.91 | $28.80 |
| 52 Week High | $55.65 | $46.02 |
| Indicator | NNNN | OBK |
|---|---|---|
| Relative Strength Index (RSI) | 49.37 | 42.46 |
| Support Level | $20.19 | $34.78 |
| Resistance Level | $31.92 | $46.02 |
| Average True Range (ATR) | 2.94 | 1.23 |
| MACD | 0.45 | -0.44 |
| Stochastic Oscillator | 52.24 | 4.19 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
Origin Bancorp Inc is a financial holding company. The bank provides a broad range of financial services to businesses, municipalities, high-net-worth individuals, and retail clients. The bank principally operates in one business segment, community banking. The bank is engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans. The bank generates the majority of its revenue from interest earned on loans and investments, service charges, and fees on deposit accounts.